Vincaleukoblastine
Analytical reference substance, ≥98%
- Product Code: 245334
Alias:
vinclinic; vinblastine, vinblastine, vinblastine tartaric acid, vinclastine
CAS:
2468-21-5
| Molecular Weight: | 336.43 g./mol | Molecular Formula: | C₂₁H₂₄N₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | 491.5°C at 760 mmHg | |
| Density: | Storage Condition: | -20°C |
Product Description:
Used primarily in cancer chemotherapy, particularly for the treatment of acute lymphoblastic leukemia and Hodgkin’s lymphoma. It works by inhibiting microtubule formation in dividing cells, thereby preventing cell division and promoting apoptosis in rapidly growing tumor cells. Commonly administered intravenously, it is part of multi-drug regimens due to its potent cytotoxic effects. Also used in some solid tumors and neurological cancers, though its use is limited by neurotoxic side effects.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿1,630.00 |
+
-
|
Vincaleukoblastine
Used primarily in cancer chemotherapy, particularly for the treatment of acute lymphoblastic leukemia and Hodgkin’s lymphoma. It works by inhibiting microtubule formation in dividing cells, thereby preventing cell division and promoting apoptosis in rapidly growing tumor cells. Commonly administered intravenously, it is part of multi-drug regimens due to its potent cytotoxic effects. Also used in some solid tumors and neurological cancers, though its use is limited by neurotoxic side effects.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :